On 30 November 2009, the American Institute of Biological Sciences (AIBS) wrote to Majority Leader Harry Reid (D-NV), Senator Max Baucus (D-MT), and Senator Christopher Dodd (D-CT) about a provision in the health care reform bill that could have negative ramifications for scientific research on comparative effectiveness of medical treatments. The letter calls for the removal of language from Section 6301 of HR 3590 that could require that research findings funded by a new Patient-Centered Outcomes Research Institute be reviewed and approved by an administrative process prior to submission for scientific peer-review and publication. If the administrative review finds that the research under review is not “within the bounds of and entirely consistent with the evidence and findings produced under the contract with the Institute”, the researcher would be suspended from receiving further funding for no less than five years. To read the letter, please visit http://www.aibs.org/position-statements/20091130healthcare_reform.html. To send a letter to your Senators about this issue, please visit http://capwiz.com/aibs/issues/alert/?alertid=14425646.
back to Public Policy Reports